☰

Jianqin Lu - Publications

Affiliations: 
School of Pharmacy University of Pittsburgh, Pittsburgh, PA, United States 
 2019- University of Arizona, Tucson, AZ 
Area:
Drug Delivery and Nanomedicine
Website:
https://jianqinlu.wixsite.com/jianqinlu
Tree Info Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Wang Z, Li W, Jiang Y, Tran TB, Cordova LE, Chung J, Kim M, Wondrak G, Erdrich J, Lu J. Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy. Nature Communications. 14: 7235. PMID 37945606 DOI: 10.1038/s41467-023-43079-4  0.715
2023 Wang Z, Gonzalez KM, Cordova LE, Lu J. Nanotechnology-empowered therapeutics targeting neurodegenerative diseases. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. e1907. PMID 37248794 DOI: 10.1002/wnan.1907  0.576
2023 Jiang T, Gonzalez KM, Cordova LE, Lu J. Nanotechnology-enabled gene delivery for cancer and other genetic diseases. Expert Opinion On Drug Delivery. 1-18. PMID 37017558 DOI: 10.1080/17425247.2023.2200246  0.3
2023 Li W, Jiang Y, Lu J. Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy. International Journal of Pharmaceutics. 122655. PMID 36720448 DOI: 10.1016/j.ijpharm.2023.122655  0.737
2022 Wang Z, Cordova LE, Chalasani P, Lu J. Camptothesome Potentiates PD-L1 Immune Checkpoint Blockade for Improved Metastatic Triple-Negative Breast Cancer Immunochemotherapy. Molecular Pharmaceutics. 19: 4665-4674. PMID 36413426 DOI: 10.1021/acs.molpharmaceut.2c00701  0.632
2022 Li W, Gonzalez KM, Chung J, Kim M, Lu J. Surface-modified nanotherapeutics targeting atherosclerosis. Biomaterials Science. PMID 35980230 DOI: 10.1039/d2bm00660j  0.683
2022 Wang Z, Li W, Park J, Gonzalez KM, Scott AJ, Lu J. Camptothesome elicits immunogenic cell death to boost colorectal cancer immune checkpoint blockade. Journal of Controlled Release : Official Journal of the Controlled Release Society. 349: 929-939. PMID 35926754 DOI: 10.1016/j.jconrel.2022.07.042  0.725
2021 Wang Z, Little N, Chen J, Lambesis KT, Le KT, Han W, Scott AJ, Lu J. Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy. Nature Nanotechnology. PMID 34385682 DOI: 10.1038/s41565-021-00950-z  0.717
2021 Li W, Little N, Park J, Foster CA, Chen J, Lu J. Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges. Molecular Pharmaceutics. PMID 34260250 DOI: 10.1021/acs.molpharmaceut.1c00455  0.717
2020 Wang Z, Chen J, Little N, Lu J. Self-assembling Prodrug Nanotherapeutics for Synergistic Tumor Targeted Drug Delivery. Acta Biomaterialia. PMID 32454086 DOI: 10.1016/J.Actbio.2020.05.026  0.721
2018 Liu X, Jiang J, Chan R, Ji Y, Lu J, Liao YP, Okene M, Lin J, Lin P, Chang CH, Wang X, Tang I, Zheng E, Qiu W, Wainberg ZA, et al. Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer. Acs Nano. PMID 30525443 DOI: 10.1021/Acsnano.8B06164  0.409
2017 Liu X, Jiang J, Ji Y, Lu J, Chan R, Meng H. Targeted drug delivery using iRGD peptide for solid cancer treatment. Molecular Systems Design & Engineering. 2: 370-379. PMID 30498580 DOI: 10.1039/C7ME00050B  0.457
2017 Lu J, Liu X, Liao YP, Salazar F, Sun B, Jiang W, Chang CH, Jiang J, Wang X, Wu AM, Meng H, Nel AE. Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression. Nature Communications. 8: 1811. PMID 29180759 DOI: 10.1038/S41467-017-01651-9  0.452
2015 He C, Lu J, Lin W. Hybrid nanoparticles for combination therapy of cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26387745 DOI: 10.1016/J.Jconrel.2015.09.029  0.449
2015 Lu J, Liu C, Wang P, Ghazwani M, Xu J, Huang Y, Ma X, Zhang P, Li S. The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin. Biomaterials. 62: 176-87. PMID 26057133 DOI: 10.1016/J.Biomaterials.2015.05.046  0.43
2014 Lu J, Zhao W, Liu H, Marquez R, Huang Y, Zhang Y, Li J, Xie W, Venkataramanan R, Xu L, Li S. An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance. Journal of Controlled Release : Official Journal of the Controlled Release Society. 196: 272-86. PMID 25456831 DOI: 10.1016/J.Jconrel.2014.10.016  0.479
2014 Zhang X, Huang Y, Zhao W, Liu H, Marquez R, Lu J, Zhang P, Zhang Y, Li J, Gao X, Venkataramanan R, Xu L, Li S. Targeted delivery of anticancer agents via a dual function nanocarrier with an interfacial drug-interactive motif. Biomacromolecules. 15: 4326-35. PMID 25325795 DOI: 10.1021/Bm501339J  0.452
2014 Lu J, Zhao W, Huang Y, Liu H, Marquez R, Gibbs RB, Li J, Venkataramanan R, Xu L, Li S, Li S. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier. Molecular Pharmaceutics. 11: 4164-78. PMID 25265550 DOI: 10.1021/Mp500389V  0.526
2014 Zhang Y, Huang Y, Zhao W, Lu J, Zhang P, Zhang X, Li J, Gao X, Venkataramanan R, Li S. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity. The Aaps Journal. 16: 1282-91. PMID 25193267 DOI: 10.1208/S12248-014-9651-2  0.45
2014 Zhang P, Huang Y, Liu H, Marquez RT, Lu J, Zhao W, Zhang X, Gao X, Li J, Venkataramanan R, Xu L, Li S. A PEG-Fmoc conjugate as a nanocarrier for paclitaxel. Biomaterials. 35: 7146-56. PMID 24856103 DOI: 10.1016/J.Biomaterials.2014.04.108  0.446
2014 Chen Y, Zhang X, Lu J, Huang Y, Li J, Li S. Targeted delivery of curcumin to tumors via PEG-derivatized FTS-based micellar system. The Aaps Journal. 16: 600-8. PMID 24706375 DOI: 10.1208/S12248-014-9595-6  0.513
2014 Zhang P, Lu J, Huang Y, Zhao W, Zhang Y, Zhang X, Li J, Venkataramanan R, Gao X, Li S. Design and evaluation of a PEGylated lipopeptide equipped with drug-interactive motifs as an improved drug carrier. The Aaps Journal. 16: 114-24. PMID 24281690 DOI: 10.1208/S12248-013-9536-9  0.44
2013 Lu J, Huang Y, Zhao W, Chen Y, Li J, Gao X, Venkataramanan R, Li S. Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel. Molecular Pharmaceutics. 10: 2880-90. PMID 23768151 DOI: 10.1021/Mp300729Y  0.376
2013 Zhang X, Lu J, Huang Y, Zhao W, Chen Y, Li J, Gao X, Venkataramanan R, Sun M, Stolz DB, Zhang L, Li S. PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel. Bioconjugate Chemistry. 24: 464-72. PMID 23425093 DOI: 10.1021/Bc300608H  0.429
2013 Gao X, Huang Y, Makhov AM, Epperly M, Lu J, Grab S, Zhang P, Rohan L, Xie XQ, Wipf P, Greenberger J, Li S. Nanoassembly of surfactants with interfacial drug-interactive motifs as tailor-designed drug carriers. Molecular Pharmaceutics. 10: 187-98. PMID 23244299 DOI: 10.1021/Mp300319M  0.399
2013 Lu J, Huang Y, Zhao W, Marquez RT, Meng X, Li J, Gao X, Venkataramanan R, Wang Z, Li S. PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers. Biomaterials. 34: 1591-600. PMID 23182923 DOI: 10.1016/J.Biomaterials.2012.10.073  0.406
2012 Huang Y, Lu J, Gao X, Li J, Zhao W, Sun M, Stolz DB, Venkataramanan R, Rohan LC, Li S. PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel. Bioconjugate Chemistry. 23: 1443-51. PMID 22681537 DOI: 10.1021/Bc3000468  0.442
Show low-probability matches.